Amy Levin to Risk
This is a "connection" page, showing publications Amy Levin has written about Risk.
Connection Strength
0.163
-
Levin AS, Otani IM, Lax T, Hochberg E, Banerji A. Reactions to Rituximab in an Outpatient Infusion Center: A 5-Year Review. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):107-113.e1.
Score: 0.126
-
Blumenthal KG, Huebner EM, Fu X, Li Y, Bhattacharya G, Levin AS, Mancini CM, Slawski BR, Banerji A. Risk-based pathway for outpatient penicillin allergy evaluations. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2411-2414.e1.
Score: 0.038